Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP14929.RASg2qpa01PMKtDzOf35FrDlLthaaZIYB_QiCp7yAoXmM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP14929.RASg2qpa01PMKtDzOf35FrDlLthaaZIYB_QiCp7yAoXmM130_assertion type Assertion NP14929.RASg2qpa01PMKtDzOf35FrDlLthaaZIYB_QiCp7yAoXmM130_head.
- NP14929.RASg2qpa01PMKtDzOf35FrDlLthaaZIYB_QiCp7yAoXmM130_assertion description "[A miR signature that is associated with clinical outcome in patients with high-risk molecular features of AML (those who have FLT3-ITD or wild-type NPM1) has been reported.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP14929.RASg2qpa01PMKtDzOf35FrDlLthaaZIYB_QiCp7yAoXmM130_provenance.
- NP14929.RASg2qpa01PMKtDzOf35FrDlLthaaZIYB_QiCp7yAoXmM130_assertion evidence source_evidence_curated NP14929.RASg2qpa01PMKtDzOf35FrDlLthaaZIYB_QiCp7yAoXmM130_provenance.
- NP14929.RASg2qpa01PMKtDzOf35FrDlLthaaZIYB_QiCp7yAoXmM130_assertion SIO_000772 19822134 NP14929.RASg2qpa01PMKtDzOf35FrDlLthaaZIYB_QiCp7yAoXmM130_provenance.
- NP14929.RASg2qpa01PMKtDzOf35FrDlLthaaZIYB_QiCp7yAoXmM130_assertion wasDerivedFrom ctd_human-20150221 NP14929.RASg2qpa01PMKtDzOf35FrDlLthaaZIYB_QiCp7yAoXmM130_provenance.
- NP14929.RASg2qpa01PMKtDzOf35FrDlLthaaZIYB_QiCp7yAoXmM130_assertion wasGeneratedBy ECO_0000218 NP14929.RASg2qpa01PMKtDzOf35FrDlLthaaZIYB_QiCp7yAoXmM130_provenance.